Pacira | PCRX - Market Capitalization


Pacira reported $1.14B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Astellas Pharma JPY 3.94T 622.52B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Cara Therapeutics USD 30M 336M Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
J&J USD 611.36B 32.21B Jun/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 998M 83M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026
Zoetis USD 30.13B 19.58B Jun/2026